Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Shahid Shah, Sameen Abbas, Irfhan Ali Bin Hyder Ali & Ahmad Salman. (2020) The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature. Expert Review of Pharmacoeconomics & Outcomes Research 20:6, pages 661-672.
Read now
Read now
Jenny Tse, Keiko Wada, Yi Wang, Dominic Coppolo, Vladimir Kushnarev & Jason Suggett. (2020) Impact of Oscillating Positive Expiratory Pressure Device Use on Post-Discharge Hospitalizations: A Retrospective Cohort Study Comparing Patients with COPD or Chronic Bronchitis Using the Aerobika® and Acapella® Devices. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2527-2538.
Read now
Read now
Ike Iheanacho, Shiyuan Zhang, Denise King, Maria Rizzo & Afisi S Ismaila. (2020) Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 439-460.
Read now
Read now
Yaozhu J. Chen, Charles Makin, Vamsi K. Bollu, Maryam Navaie & Bartolome R. Celli. (2016) Exacerbations, health services utilization, and costs in commercially-insured COPD patients treated with nebulized long-acting 2-agonists. Journal of Medical Economics 19:1, pages 11-20.
Read now
Read now
David M Kern, Setareh A Williams, Ozgur Tunceli, Catrin Wessman, Siting Zhou, Ned Pethick, Hanaa Elhefni & Frank Trudo. (2014) A US database study characterizing patients initiating a budesonide–formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 775-783.
Read now
Read now
Articles from other publishers (17)
Ting Yang, Baiqiang Cai, Bin Cao, Jian Kang, Fuqiang Wen, Yahong Chen, Wenhua Jian & Chen Wang. (2023) Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL). Therapeutic Advances in Respiratory Disease 17, pages 175346662311673.
Crossref
Crossref
Michael A. Steinman, Bocheng Jing, Sachin J. Shah, Anael Rizzo, Sei J. Lee, Kenneth E. Covinsky, Christine S. Ritchie & W. John Boscardin. (2022) Development and validation of novel multimorbidity indices for older adults. Journal of the American Geriatrics Society 71:1, pages 121-135.
Crossref
Crossref
Vivianne Landry, Patrick Coburn, Karen Kost, Xinyu Liu & Nicole Y. K. Li-Jessen. (2022) Diagnostic Accuracy of Liquid Biomarkers in Airway Diseases: Toward Point-of-Care Applications. Frontiers in Medicine 9.
Crossref
Crossref
Marta Erdal, Ane Johannessen, Per Bakke, Amund Gulsvik, Tomas Mikal Eagan & Rune Nielsen. (2020) Incremental costs of COPD exacerbations in GOLD stage 2+ COPD in ever-smokers of a general population. Respiratory Medicine: X 2, pages 100014.
Crossref
Crossref
Radisa Pavlovic, Svetlana Stojkov & Zahida Binakaj. (2020) Costs of Treatment of Severe COPD Exacerbation in Serbia. Serbian Journal of Experimental and Clinical Research 21:1, pages 51-58.
Crossref
Crossref
Suzanne G Bollmeier & Aaron P Hartmann. (2020) Management of chronic obstructive pulmonary disease: A review focusing on exacerbations. American Journal of Health-System Pharmacy 77:4, pages 259-268.
Crossref
Crossref
Richard H. Stanford, Emily D. Parker, Tyler K. Reinsch, Ami R. Buikema & Cori Blauer-Peterson. (2019) Assessment of COPD-related outcomes in patients initiating a once daily or twice daily ICS/LABA. Respiratory Medicine 150, pages 1-7.
Crossref
Crossref
Hyung Jun Park, Soo Han KimHo-Cheol KimBo Young LeeSei Won LeeJae Seung LeeSang-Do LeeJoon Beom Seo & Yeon-Mok Oh. (2019) Utility of Computed Tomography in a Differential Diagnosis for the Patients with an Initial Diagnosis of Chronic Obstructive Pulmonary Disease Exacerbation. Tuberculosis and Respiratory Diseases 82:3, pages 234.
Crossref
Crossref
Richard H. StanfordMatthew S. LauYong LiStephen Stemkowski. (2019) External Validation of a COPD Risk Measure in a Commercial and Medicare Population: The COPD Treatment Ratio. Journal of Managed Care & Specialty Pharmacy 25:1, pages 58-69.
Crossref
Crossref
Robert S. Zeiger, Trung N. Tran, Rebecca K. Butler, Michael Schatz, Qiaowu Li, Deepak B. Khatry, Ubaldo Martin, Aniket A. Kawatkar & Wansu Chen. (2018) Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease. The Journal of Allergy and Clinical Immunology: In Practice 6:3, pages 944-954.e5.
Crossref
Crossref
Chakkarin Burudpakdee, Arpamas Seetasith, Patrick Dunne, Garry Kauffman, Brian Carlin, Dom Coppolo & Jason Suggett. (2017) A Real-World Study of 30-Day Exacerbation Outcomes in Chronic Obstructive Pulmonary Disease (COPD) Patients Managed with Aerobika OPEP. Pulmonary Therapy 3:1, pages 163-171.
Crossref
Crossref
A. Bourdin & N. Molinari. (2017) Quelles sont les conséquences socio-économiques des exacerbations de BPCO ?. Revue des Maladies Respiratoires 34:4, pages 338-342.
Crossref
Crossref
Dave Singh, Alberto Papi, Massimo Corradi, Ilona Pavlišová, Isabella Montagna, Catherine Francisco, Géraldine Cohuet, Stefano Vezzoli, Mario Scuri & Jørgen Vestbo. (2016) Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial. The Lancet 388:10048, pages 963-973.
Crossref
Crossref
Richard H. Stanford, Arpita Nag, Douglas W. Mapel, Todd A. Lee, Richard Rosiello, Francis Vekeman, Marjolaine Gauthier-Loiselle, Mei Sheng Duh, J. F. Philip Merrigan & Michael Schatz. (2016) Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data. Annals of the American Thoracic Society 13:7, pages 1067-1075.
Crossref
Crossref
Amol D. Dhamane, Edward A. Witt & Jun Su. (2016) Associations Between COPD Severity and Work Productivity, Health-Related Quality of Life, and Health Care Resource Use. Journal of Occupational & Environmental Medicine 58:6, pages e191-e197.
Crossref
Crossref
Yanni F. Yu, Ning Wu, Chien-Chia Chuang, Rosa Wang, Xiaoyun Pan, Nicole N. Benjamin, Giovanna Devercelli & David B. Coultas. (2016) Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis. Journal of Managed Care & Specialty Pharmacy 22:4, pages 414-423.
Crossref
Crossref
Victor Kim & Gerard J. Criner. (2015) The chronic bronchitis phenotype in chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 21:2, pages 133-141.
Crossref
Crossref